MedTrace Logo

Premenstrual Dysphoric Disorder and Antiepileptic Drugs

NCT00612235 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 80

Last updated 2018-10-26

Study results available
· View outcomes & findings →

Summary

This study is being done to determine if there are differences in mood during the menstrual cycle among women with epilepsy who take various different antiepileptic drugs and women without epilepsy.

Conditions

Interventions

DRUG

Lamotrigine

Subjects had at least 3 months on a stable dosage of lamotrigine monotherapy.

DRUG

Levetiracetam

Subjects had at least 3 months on a stable dosage of levetiracetam monotherapy.

DRUG

Carbamazepine

Subjects had at least 3 months on a stable dosage of carbamazepine monotherapy.

OTHER

No Intervention

No intervention was given

Sponsors & Collaborators

Principal Investigators

  • Andrew G Herzog, MD · Beth Israel Deaconess Medical Center

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2008-04-30
Primary Completion
2010-06-30
Completion
2010-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs
Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00612235 on ClinicalTrials.gov